• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经元特异性基因治疗可缓解庞贝病小鼠的运动障碍。

A Neuron-Specific Gene Therapy Relieves Motor Deficits in Pompe Disease Mice.

机构信息

Department of Medical Genetics, National Taiwan University Hospital, Taipei, 10041, Taiwan.

Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, 10041, Taipei, Taiwan.

出版信息

Mol Neurobiol. 2018 Jun;55(6):5299-5309. doi: 10.1007/s12035-017-0763-4. Epub 2017 Sep 11.

DOI:10.1007/s12035-017-0763-4
PMID:28895054
Abstract

In Pompe disease, deficient lysosomal acid α-glucosidase (GAA) activity causes glycogen accumulation in the muscles, which leads to weakness, cardiomyopathy, and respiratory failure. Although glycogen accumulation also occurs in the nervous system, the burden of neurological deficits in Pompe disease remains obscure. In this study, a neuron-specific gene therapy was administered to Pompe mice through intracerebroventricular injection of a viral vector carrying a neuron-specific promoter. The results revealed that gene therapy increased GAA activity and decreased glycogen content in the brain and spinal cord but not in the muscles of Pompe mice. Gene therapy only slightly increased the muscle strength of Pompe mice but substantially improved their performance on the rotarod, a test measuring motor coordination. Gene therapy also decreased astrogliosis and increased myelination in the brain and spinal cord of Pompe mice. Therefore, a neuron-specific treatment improved the motor coordination of Pompe mice by lowering glycogen accumulation, decreasing astrogliosis, and increasing myelination. These findings indicate that neurological deficits are responsible for a significant burden in Pompe disease.

摘要

在庞贝病中,溶酶体酸性α-葡萄糖苷酶(GAA)活性的缺乏导致肌肉中的糖原积累,从而导致肌肉无力、心肌病和呼吸衰竭。尽管糖原也在神经系统中积累,但庞贝病的神经缺陷负担仍然不清楚。在这项研究中,通过向携带神经元特异性启动子的病毒载体进行脑室内注射,对庞贝病小鼠进行了神经元特异性基因治疗。结果表明,基因治疗增加了 GAA 活性并降低了庞贝病小鼠大脑和脊髓中的糖原含量,但对肌肉没有影响。基因治疗仅略微增加了庞贝病小鼠的肌肉力量,但显著改善了它们在旋转棒上的表现,旋转棒是一种测量运动协调能力的测试。基因治疗还减少了庞贝病小鼠大脑和脊髓中的星形胶质细胞增生并增加了髓鞘形成。因此,神经元特异性治疗通过降低糖原积累、减少星形胶质细胞增生和增加髓鞘形成,改善了庞贝病小鼠的运动协调能力。这些发现表明,神经缺陷是庞贝病的一个重要负担。

相似文献

1
A Neuron-Specific Gene Therapy Relieves Motor Deficits in Pompe Disease Mice.神经元特异性基因治疗可缓解庞贝病小鼠的运动障碍。
Mol Neurobiol. 2018 Jun;55(6):5299-5309. doi: 10.1007/s12035-017-0763-4. Epub 2017 Sep 11.
2
Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects.基因治疗分泌酸性α-葡萄糖苷酶可挽救新型早发性脊髓和呼吸缺陷 Pompe 病小鼠模型。
EBioMedicine. 2020 Nov;61:103052. doi: 10.1016/j.ebiom.2020.103052. Epub 2020 Oct 9.
3
Systemic Delivery of AAVB1-GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease.AAVB1-GAA 全身递送可清除糖原并延长庞贝病小鼠模型的生存期。
Hum Gene Ther. 2019 Jan;30(1):57-68. doi: 10.1089/hum.2018.016. Epub 2018 Jul 25.
4
Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.基因治疗联合共受体阻断和β2激动剂对小鼠庞贝病的协同疗效。
Hum Gene Ther. 2015 Nov;26(11):743-50. doi: 10.1089/hum.2015.033. Epub 2015 Sep 29.
5
Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice.8型腺相关病毒介导酸性α-葡萄糖苷酶在肝脏中表达以纠正症状前和有症状的庞贝氏症小鼠生化及运动功能缺陷的能力。
Hum Gene Ther. 2008 Jun;19(6):609-21. doi: 10.1089/hum.2008.010.
6
Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease.鞘内基因治疗对庞贝病的长期神经和心脏矫正作用。
Acta Neuropathol Commun. 2017 Sep 6;5(1):66. doi: 10.1186/s40478-017-0464-2.
7
Efficacious Androgen Hormone Administration in Combination with Adeno-Associated Virus Vector-Mediated Gene Therapy in Female Mice with Pompe Disease.在患有庞贝病的雌性小鼠中,有效的雄激素激素给药与腺相关病毒载体介导的基因治疗相结合。
Hum Gene Ther. 2022 May;33(9-10):479-491. doi: 10.1089/hum.2021.218. Epub 2022 May 4.
8
Impaired clearance of accumulated lysosomal glycogen in advanced Pompe disease despite high-level vector-mediated transgene expression.尽管载体介导的转基因表达水平很高,但晚期庞贝病中累积的溶酶体糖原清除受损。
J Gene Med. 2009 Oct;11(10):913-20. doi: 10.1002/jgm.1372.
9
Spinal delivery of AAV vector restores enzyme activity and increases ventilation in Pompe mice.鞘内注射 AAV 载体可恢复 Pompe 小鼠的酶活性并增加通气量。
Mol Ther. 2012 Jan;20(1):21-7. doi: 10.1038/mt.2011.214. Epub 2011 Oct 18.
10
Muscle-specific, liver-detargeted adeno-associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa mice.肌肉特异性、肝脏靶向的腺相关病毒基因治疗可挽救成年和新生 Gaa 小鼠的庞贝病表型。
J Inherit Metab Dis. 2024 Jan;47(1):119-134. doi: 10.1002/jimd.12625. Epub 2023 May 29.

引用本文的文献

1
GAA replacement improves respiratory muscle, neural, and alveolar pathology in the pompe mouse.糖原累积酶替代疗法可改善庞贝氏症小鼠的呼吸肌、神经及肺泡病变。
Respir Physiol Neurobiol. 2025 Jul;335:104433. doi: 10.1016/j.resp.2025.104433. Epub 2025 Apr 25.
2
Management of Pompe disease alongside and beyond ERT: a narrative review.庞贝病在酶替代疗法及其他方面的管理:一篇叙述性综述
Acta Myol. 2025 Mar;44(1):11-22. doi: 10.36185/2532-1900-1106.
3
A novel CD71 Centyrin:Gys1 siRNA conjugate reduces glycogen synthesis and glycogen levels in a mouse model of Pompe disease.

本文引用的文献

1
Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).自互补腺相关病毒9型基因递送部分纠正与青少年神经元蜡样脂褐质沉积症(CLN3)相关的病理变化。
J Neurosci. 2016 Sep 14;36(37):9669-82. doi: 10.1523/JNEUROSCI.1635-16.2016.
2
Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study.新生儿期接受治疗的婴儿型庞贝病患者的缓慢进行性肌病:一项肌肉磁共振成像研究
Orphanet J Rare Dis. 2016 May 17;11(1):63. doi: 10.1186/s13023-016-0446-7.
3
Cognitive decline in classic infantile Pompe disease: An underacknowledged challenge.
一种新型的CD71 Centyrin:Gys1小干扰RNA偶联物可降低庞贝病小鼠模型中的糖原合成及糖原水平。
Mol Ther. 2025 Jan 8;33(1):235-248. doi: 10.1016/j.ymthe.2024.11.033. Epub 2024 Nov 26.
4
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations.临床前慢病毒造血干细胞基因治疗纠正庞贝病相关的肌肉和神经表现。
Mol Ther. 2024 Nov 6;32(11):3847-3864. doi: 10.1016/j.ymthe.2024.09.024. Epub 2024 Sep 17.
5
Neurological glycogen storage diseases and emerging therapeutics.神经糖原贮积病和新兴治疗方法。
Neurotherapeutics. 2024 Sep;21(5):e00446. doi: 10.1016/j.neurot.2024.e00446. Epub 2024 Sep 14.
6
Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy.庞贝病治疗进展:从酶替代疗法到基因治疗。
Mol Diagn Ther. 2024 Nov;28(6):703-719. doi: 10.1007/s40291-024-00733-x. Epub 2024 Aug 12.
7
A Comprehensive Update on Late-Onset Pompe Disease.晚期庞贝病的全面更新。
Biomolecules. 2023 Aug 22;13(9):1279. doi: 10.3390/biom13091279.
8
The multifaceted roles of the brain glycogen.脑糖原的多面角色。
J Neurochem. 2024 May;168(5):728-743. doi: 10.1111/jnc.15926. Epub 2023 Aug 9.
9
AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice.腺相关病毒介导的分泌型酸性α-葡萄糖苷酶转导增强摄取纠正庞贝病小鼠的神经肌肉病理。
JCI Insight. 2023 Aug 22;8(16):e170199. doi: 10.1172/jci.insight.170199.
10
Gene therapy for glycogen storage diseases.糖原贮积病的基因治疗。
J Inherit Metab Dis. 2024 Jan;47(1):93-118. doi: 10.1002/jimd.12654. Epub 2023 Jul 27.
经典型婴儿庞贝病中的认知衰退:一个未得到充分认识的挑战。
Neurology. 2016 Mar 29;86(13):1260-1. doi: 10.1212/WNL.0000000000002523. Epub 2016 Mar 4.
4
Astrocyte roles in traumatic brain injury.星形胶质细胞在创伤性脑损伤中的作用。
Exp Neurol. 2016 Jan;275 Pt 3(0 3):305-315. doi: 10.1016/j.expneurol.2015.03.020. Epub 2015 Mar 28.
5
Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth.新生儿筛查诊断、并从出生开始治疗的婴儿起病庞贝病患者的长期预后。
J Pediatr. 2015 Apr;166(4):985-91.e1-2. doi: 10.1016/j.jpeds.2014.10.068. Epub 2014 Nov 4.
6
Motor skill learning requires active central myelination.运动技能学习需要活跃的中枢髓鞘形成。
Science. 2014 Oct 17;346(6207):318-22. doi: 10.1126/science.1254960.
7
Peripheral nerve and neuromuscular junction pathology in Pompe disease.庞贝病中的周围神经和神经肌肉接头病理学
Hum Mol Genet. 2015 Feb 1;24(3):625-36. doi: 10.1093/hmg/ddu476. Epub 2014 Sep 12.
8
Transient low-dose methotrexate generates B regulatory cells that mediate antigen-specific tolerance to alglucosidase alfa.短暂低剂量甲氨蝶呤可产生B调节细胞,这些细胞介导对阿糖苷酶α的抗原特异性耐受。
J Immunol. 2014 Oct 15;193(8):3947-58. doi: 10.4049/jimmunol.1303326. Epub 2014 Sep 10.
9
Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of CNS myelination.哺乳动物雷帕霉素靶蛋白促进少突胶质细胞分化、中枢神经系统髓鞘形成的启动和范围。
J Neurosci. 2014 Mar 26;34(13):4453-65. doi: 10.1523/JNEUROSCI.4311-13.2014.
10
Enzyme replacement in neuronal storage disorders in the pediatric population.儿科人群神经元贮积病的酶替代治疗。
Curr Treat Options Neurol. 2013 Oct;15(5):634-51. doi: 10.1007/s11940-013-0256-3.